Acemetacin 53164-05-9
Acemetacin is a non-steroidal anti-inflammatory drug, used for the treatment of osteoarthritis, rheumatoid arthritis, lower back pain, and relieving post-operative pain. It is manufactured by Merck under the tradename Emflex, and is available in the UK as a prescription-only drug. Acemetacin, a glycolic acid ester of indometacin, acts as a prodrug; in the body, it is metabolized to indometacin, which then acts as an inhibitor of cyclooxygenase, producing the anti-inflammatory effects. An advantage of acemetacin is that it reduces gastric damage when compared to indometacin. {{Anti-inflammatory and antirheumatic products
read more [+]| Systematic (IUPAC) name: | 2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid |
|---|---|
| Acemetacin CAS number: | 53164-05-9 |
| ATC code: | M01AB11 |
| PubChem: | 1981 |
| DrugBank: | |
| Formula: | C21H18N1O6 |
| Molecular mass: | 415.82372 g/mol |
| Acemetacin Assay/Purity: | Typically NLT 98% |
